Abstract
Oropharyngeal colonization with pathogenic organisms is a near-universal occurrence in critically ill patients receiving mechanical ventilation. Aspiration of these bacteria from the oral cavity and pharynx into the lower respiratory tract contributes to the development of ventilator-associated pneumonia (VAP). Colonization of dental plaque by Gramnegative bacteria has been recognized as an important contributor to the oropharyngeal bacterial pool in ICU patients. Lack of spontaneous movements of the tongue and jaws, reduction of salivary flow, infrequent swallowing, and inability to clean oral cavity and brush teeth because of orotracheal intubation or altered mental status result in biofilm and dental plaque formation. Oral hygiene has been proposed as a key intervention for reducing VAP. Strategies to eradicate oropharyngeal colonization by antiseptic oral care, such as chlorhexidine have been shown to reduce the oral microbial colonization and risk of VAP but failed to reduce duration of mechanical ventilation, ICU length of stay or mortality. Using chlorhexidine for oral antisepsis is simple and inexpensive with a low level of adverse effects but optimal concentration, technique and frequency of application warrant further studies.
Keywords: Ventilator-associated pneumonia, oral hygiene, dental plaque, selective oropharyngeal decontamination, chlorhexidine
Current Respiratory Medicine Reviews
Title: Oral Hygiene and Ventilator-Associated Pneumonia
Volume: 6 Issue: 1
Author(s): Laurent Robriquet and Francois Fourrier
Affiliation:
Keywords: Ventilator-associated pneumonia, oral hygiene, dental plaque, selective oropharyngeal decontamination, chlorhexidine
Abstract: Oropharyngeal colonization with pathogenic organisms is a near-universal occurrence in critically ill patients receiving mechanical ventilation. Aspiration of these bacteria from the oral cavity and pharynx into the lower respiratory tract contributes to the development of ventilator-associated pneumonia (VAP). Colonization of dental plaque by Gramnegative bacteria has been recognized as an important contributor to the oropharyngeal bacterial pool in ICU patients. Lack of spontaneous movements of the tongue and jaws, reduction of salivary flow, infrequent swallowing, and inability to clean oral cavity and brush teeth because of orotracheal intubation or altered mental status result in biofilm and dental plaque formation. Oral hygiene has been proposed as a key intervention for reducing VAP. Strategies to eradicate oropharyngeal colonization by antiseptic oral care, such as chlorhexidine have been shown to reduce the oral microbial colonization and risk of VAP but failed to reduce duration of mechanical ventilation, ICU length of stay or mortality. Using chlorhexidine for oral antisepsis is simple and inexpensive with a low level of adverse effects but optimal concentration, technique and frequency of application warrant further studies.
Export Options
About this article
Cite this article as:
Robriquet Laurent and Fourrier Francois, Oral Hygiene and Ventilator-Associated Pneumonia, Current Respiratory Medicine Reviews 2010; 6 (1) . https://dx.doi.org/10.2174/157339810790820421
DOI https://dx.doi.org/10.2174/157339810790820421 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nanomaterials for Photohyperthermia: A Review
Current Pharmaceutical Design Diagnostic and Therapeutic Nanoparticles in Cardiovascular Diseases
Current Pharmaceutical Design Hallmarks in the Therapeutic Approach of Aortic Aneurysms: The Main Contributors
Current Pharmaceutical Design Isolation of <i>Morganella Morganii</i> and <i>Providencia</i> Species from Clinical Samples in a Tertiary Care Hospital in North India
Infectious Disorders - Drug Targets Insights into Airway Infections by Enterococci: A Review
Recent Patents on Anti-Infective Drug Discovery Sutureless Aortic Valve Replacement Using Perceval S Valve
Recent Patents on Cardiovascular Drug Discovery Valve Endothelial Cells – Not Just Any Old Endothelial Cells
Current Vascular Pharmacology Polyproline and Triple Helix Motifs in Host-Pathogen Recognition
Current Protein & Peptide Science Preparation, Crystallization and Preliminary X-Ray Analysis of Threonine Synthase from Streptococcus mutans
Protein & Peptide Letters Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology How Do Periodontal Infections Affect the Onset and Progression of Alzheimer’s Disease?
CNS & Neurological Disorders - Drug Targets Cardioembolic Stroke: Clinical Features, Specific Cardiac Disorders and Prognosis
Current Cardiology Reviews Exploring the Biology and Structural Architecture of Sortase Role on Biofilm Formation in Gram Positive Pathogens
Current Topics in Medicinal Chemistry Management of Asymptomatic Severe Aortic Stenosis
Current Cardiology Reviews Coarctation of the Aorta - An Evolution of Therapeutic Options
Current Cardiology Reviews Virtual Screening for the Development of New Effective Compounds Against Staphylococcus aureus
Current Medicinal Chemistry Current Advances in the Identification and Characterization of Putative Drug and Vaccine Targets in the Bacterial Genomes
Current Topics in Medicinal Chemistry Lantibiotic Production by Pathogenic Microorganisms
Current Protein & Peptide Science Models of In-Vivo Bacterial Infections for the Development of Antimicrobial Peptide-based Drugs
Current Topics in Medicinal Chemistry New Approaches to Develop Anti-Staphylococcal Agents
Current Medicinal Chemistry - Anti-Infective Agents